A lay doctor's guide to the inflammatory process in the gastrointestinal tract.
作者信息
Pathmakanthan S, Hawkey C J
机构信息
Division of Gastroenterology, University Hospital, Queens Medical Centre, Nottingham NG7 2UH, UK.
出版信息
Postgrad Med J. 2000 Oct;76(900):611-7. doi: 10.1136/pmj.76.900.611.
Abstract
摘要
相似文献
1
A lay doctor's guide to the inflammatory process in the gastrointestinal tract.
Postgrad Med J. 2000 Oct;76(900):611-7. doi: 10.1136/pmj.76.900.611.
2
[Immunopathogenesis of inflammatory bowel diseases: new approaches for therapy?].
Schweiz Med Wochenschr. 1998 Jan 6;128(1-2):11-4.
3
Protective and pathogenic roles of cytokines in inflammatory bowel diseases.
J Investig Med. 1996 Dec;44(9):516-21.
4
Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.
Gut. 2009 Dec;58(12):1629-36. doi: 10.1136/gut.2009.182170. Epub 2009 Sep 8.
5
[The cytokines in inflammatory bowel disease].
Postepy Hig Med Dosw (Online). 2009 Aug 18;63:389-94.
6
Cytokines and growth factor modulators in intestinal inflammation and repair.
J Pathol. 2005 Mar;205(4):417-25. doi: 10.1002/path.1722.
7
Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract.
Curr Opin Gastroenterol. 2013 Nov;29(6):581-7. doi: 10.1097/MOG.0b013e328365d339.
8
Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
Gut. 2007 Feb;56(2):293-303. doi: 10.1136/gut.2005.090464. Epub 2006 Sep 6.
9
The immunological basis of inflammatory bowel disease.
Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):142-4.
10
[Immunobiology of chronic inflammatory bowel diseases].
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2657-60. doi: 10.1055/s-2006-956271.
引用本文的文献
1
Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review.
Arch Toxicol. 2024 Nov;98(11):3519-3541. doi: 10.1007/s00204-024-03844-w. Epub 2024 Sep 9.
2
Maintenance of gut barrier integrity after injury: Trust your gut microRNAs.
J Leukoc Biol. 2021 Nov;110(5):979-986. doi: 10.1002/JLB.3RU0120-090RR. Epub 2021 Feb 12.
3
Lysozyme transgenic goats' milk positively impacts intestinal cytokine expression and morphology.
Transgenic Res. 2011 Dec;20(6):1235-43. doi: 10.1007/s11248-011-9489-7. Epub 2011 Feb 11.
本文引用的文献
1
Review article: Homing of mucosal immune cells--a possible connection between intestinal and articular inflammation.
Aliment Pharmacol Ther. 1997 Dec;11 Suppl 3:24-37; discussion 37-9. doi: 10.1111/j.1365-2036.1997.tb00806.x.
2
Eicosanoids: role in gastrointestinal inflammation and cancer.
Eur J Gastroenterol Hepatol. 1997 Nov;9(11):1033-44. doi: 10.1097/00042737-199711000-00003.
3
Nitric oxide--a mediator of inflammation or mucosal defence.
Eur J Gastroenterol Hepatol. 1997 Nov;9(11):1026-32. doi: 10.1097/00042737-199711000-00002.
4
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis.
Aliment Pharmacol Ther. 1997 Oct;11(5):853-8. doi: 10.1046/j.1365-2036.1997.00225.x.
5
Epithelial cells as sensors for microbial infection.
J Clin Invest. 1997 Jul 1;100(1):6-10. doi: 10.1172/JCI119522.
6
Antimicrobial peptides in the gastrointestinal tract.
Gut. 1997 Feb;40(2):161-3. doi: 10.1136/gut.40.2.161.
7
Regulatory cytokines in inflammatory bowel disease.
Aliment Pharmacol Ther. 1996;10 Suppl 2:75-9; discussion 80. doi: 10.1046/j.1365-2036.1996.22164024.x.
8
Major pathways of mucosal immunity and inflammation: cell activation, cytokine production and the role of bacterial factors.
Aliment Pharmacol Ther. 1996;10 Suppl 2:1-9. doi: 10.1046/j.1365-2036.1996.22164000.x.
9
Lymphocyte homing and homeostasis.
Science. 1996 Apr 5;272(5258):60-6. doi: 10.1126/science.272.5258.60.
10
The molecular descent of the major histocompatibility complex.
Annu Rev Immunol. 1993;11:269-95. doi: 10.1146/annurev.iy.11.040193.001413.
Zotero 插件